GB1590525A - Biological analysis - Google Patents
Biological analysis Download PDFInfo
- Publication number
- GB1590525A GB1590525A GB5174076A GB5174076A GB1590525A GB 1590525 A GB1590525 A GB 1590525A GB 5174076 A GB5174076 A GB 5174076A GB 5174076 A GB5174076 A GB 5174076A GB 1590525 A GB1590525 A GB 1590525A
- Authority
- GB
- United Kingdom
- Prior art keywords
- particulate
- reagent
- reagents
- particles
- agglutination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004458 analytical method Methods 0.000 title description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 91
- 239000002245 particle Substances 0.000 claims description 68
- 238000000034 method Methods 0.000 claims description 46
- 230000004520 agglutination Effects 0.000 claims description 39
- 239000004816 latex Substances 0.000 claims description 35
- 229920000126 latex Polymers 0.000 claims description 35
- 238000003556 assay Methods 0.000 claims description 32
- 239000000126 substance Substances 0.000 claims description 32
- 239000000203 mixture Substances 0.000 claims description 17
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 13
- 229960003387 progesterone Drugs 0.000 claims description 8
- 239000000186 progesterone Substances 0.000 claims description 8
- 230000003287 optical effect Effects 0.000 claims description 6
- 241000283690 Bos taurus Species 0.000 claims description 5
- 239000000427 antigen Substances 0.000 claims description 4
- 102000036639 antigens Human genes 0.000 claims description 4
- 108091007433 antigens Proteins 0.000 claims description 4
- 230000000984 immunochemical effect Effects 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 235000013336 milk Nutrition 0.000 claims description 4
- 239000008267 milk Substances 0.000 claims description 4
- 210000004080 milk Anatomy 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 150000003431 steroids Chemical class 0.000 claims description 2
- 238000010998 test method Methods 0.000 claims description 2
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 15
- 229960005156 digoxin Drugs 0.000 description 15
- 239000000523 sample Substances 0.000 description 15
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 14
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 14
- 210000002966 serum Anatomy 0.000 description 14
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
- 241000282414 Homo sapiens Species 0.000 description 8
- 229940027941 immunoglobulin g Drugs 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 238000011534 incubation Methods 0.000 description 7
- 230000005764 inhibitory process Effects 0.000 description 7
- 239000000178 monomer Substances 0.000 description 7
- 239000002953 phosphate buffered saline Substances 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 7
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 102000004576 Placental Lactogen Human genes 0.000 description 6
- 108010003044 Placental Lactogen Proteins 0.000 description 6
- 239000000381 Placental Lactogen Substances 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 229940098773 bovine serum albumin Drugs 0.000 description 6
- 229940034208 thyroxine Drugs 0.000 description 6
- 239000004471 Glycine Substances 0.000 description 4
- 239000004793 Polystyrene Substances 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 239000011236 particulate material Substances 0.000 description 4
- 229920002223 polystyrene Polymers 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 101000766306 Homo sapiens Serotransferrin Proteins 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000008857 Ferritin Human genes 0.000 description 2
- 108050000784 Ferritin Proteins 0.000 description 2
- 238000008416 Ferritin Methods 0.000 description 2
- 108091006905 Human Serum Albumin Proteins 0.000 description 2
- 206010027146 Melanoderma Diseases 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 102000004338 Transferrin Human genes 0.000 description 2
- 108090000901 Transferrin Proteins 0.000 description 2
- 108091008324 binding proteins Proteins 0.000 description 2
- 239000007975 buffered saline Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000012207 quantitative assay Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 235000017550 sodium carbonate Nutrition 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000012581 transferrin Substances 0.000 description 2
- 238000004879 turbidimetry Methods 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 1
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- 101000942118 Homo sapiens C-reactive protein Proteins 0.000 description 1
- 101000798114 Homo sapiens Lactotransferrin Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 1
- 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 229910017974 NH40H Inorganic materials 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960002319 barbital Drugs 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 102000050459 human LTF Human genes 0.000 description 1
- 238000005691 oxidative coupling reaction Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000006578 reductive coupling reaction Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5174076A GB1590525A (en) | 1976-12-10 | 1976-12-10 | Biological analysis |
| DE19772754645 DE2754645C2 (de) | 1976-12-10 | 1977-12-08 | Verfahren zum Nachweis und zur Bestimmung von Antigenen oder Antikörpern in Flüssigkeiten |
| CA292,691A CA1089360A (en) | 1976-12-10 | 1977-12-08 | Antigen or antibody testing using inhibition of the agglutination of two particulate reagents |
| FR7737122A FR2392387A1 (fr) | 1976-12-10 | 1977-12-09 | Procede pour la mise en evidence d'un antigene ou d'un anticorps particuliers dans un liquide |
| JP14777277A JPS53104726A (en) | 1976-12-10 | 1977-12-10 | Test method of liquid containing specific antigen ag or antibody ab |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5174076A GB1590525A (en) | 1976-12-10 | 1976-12-10 | Biological analysis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1590525A true GB1590525A (en) | 1981-06-03 |
Family
ID=10461194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB5174076A Expired GB1590525A (en) | 1976-12-10 | 1976-12-10 | Biological analysis |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPS53104726A (enrdf_load_stackoverflow) |
| CA (1) | CA1089360A (enrdf_load_stackoverflow) |
| DE (1) | DE2754645C2 (enrdf_load_stackoverflow) |
| FR (1) | FR2392387A1 (enrdf_load_stackoverflow) |
| GB (1) | GB1590525A (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0090966A1 (de) * | 1982-04-05 | 1983-10-12 | American Hospital Supply Corporation | Verfahren zur Antigen-Bestimmung |
| WO1989001161A1 (en) * | 1987-07-28 | 1989-02-09 | International Institute Of Cellular & Molecular Pa | Turbidimetric assay |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4191739A (en) * | 1977-10-17 | 1980-03-04 | General Electric Company | Antigen-antibody reaction assay employing particle aggregation and resistive pulse analysis |
| GB2045431B (en) * | 1979-02-26 | 1983-04-20 | Technicon Instr | Immunoassay utilising two particulate reagents |
| DE2918342A1 (de) * | 1979-05-07 | 1980-11-20 | Behringwerke Ag | Latex-reagenz |
| JPS5821166A (ja) * | 1981-07-30 | 1983-02-07 | Fujitsu Ltd | 被測定物質分離方式 |
| GB2123146B (en) * | 1982-06-28 | 1985-09-25 | Abbott Lab | Dual parameter flow immunoassays |
| JPH0619349B2 (ja) * | 1983-11-22 | 1994-03-16 | 東亜医用電子株式会社 | 体液成分分析方法およびその装置 |
| JPH0619350B2 (ja) * | 1984-05-17 | 1994-03-16 | 東亜医用電子株式会社 | 体液成分分析方法およびその装置 |
| JPS61120060A (ja) * | 1984-11-16 | 1986-06-07 | Dai Ichi Pure Chem Co Ltd | 全自動連続分析装置 |
| CN111965277A (zh) * | 2020-08-06 | 2020-11-20 | 天津科德通生物科技有限公司 | 一种抗体纯化流出液自动收集装置 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3639558A (en) * | 1968-02-19 | 1972-02-01 | Louis Csizmas | Immunological reagent particles having proteinaceous materials covalently bonded thereto |
-
1976
- 1976-12-10 GB GB5174076A patent/GB1590525A/en not_active Expired
-
1977
- 1977-12-08 CA CA292,691A patent/CA1089360A/en not_active Expired
- 1977-12-08 DE DE19772754645 patent/DE2754645C2/de not_active Expired
- 1977-12-09 FR FR7737122A patent/FR2392387A1/fr active Granted
- 1977-12-10 JP JP14777277A patent/JPS53104726A/ja active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0090966A1 (de) * | 1982-04-05 | 1983-10-12 | American Hospital Supply Corporation | Verfahren zur Antigen-Bestimmung |
| WO1989001161A1 (en) * | 1987-07-28 | 1989-02-09 | International Institute Of Cellular & Molecular Pa | Turbidimetric assay |
Also Published As
| Publication number | Publication date |
|---|---|
| CA1089360A (en) | 1980-11-11 |
| JPS6217188B2 (enrdf_load_stackoverflow) | 1987-04-16 |
| FR2392387B1 (enrdf_load_stackoverflow) | 1982-05-14 |
| DE2754645C2 (de) | 1986-11-20 |
| FR2392387A1 (fr) | 1978-12-22 |
| DE2754645A1 (de) | 1978-06-22 |
| JPS53104726A (en) | 1978-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4184849A (en) | Mixed agglutination | |
| US4279617A (en) | Iummunoassay involving agglutination | |
| CA1332043C (en) | Latex agglutination immunoassay in the presence of hemoglobin | |
| EP0267317B1 (en) | Method for the detection of proteins and viruses | |
| US5518887A (en) | Immunoassays empolying generic anti-hapten antibodies and materials for use therein | |
| EP0321261B1 (en) | Use of immobilized biotinylated receptor in test device, kit and method for determining a ligand | |
| JPH03502246A (ja) | 物質の分析のための凝集方法 | |
| CA1174596A (en) | Particle agglutination assay | |
| WO1993020446A1 (en) | Immunoassays employing generic anti-hapten antibodies and materials for use therein | |
| EP0564494B1 (en) | Test method and reagent kit therefor | |
| GB1590525A (en) | Biological analysis | |
| US4828978A (en) | Agglutination reagent and method of preparing same | |
| JP3220546B2 (ja) | 免疫複合体存在下の抗原または抗体の測定方法 | |
| CA1234044A (en) | Specific binding assay reagent | |
| US5843794A (en) | Technique for the prevention of false positive reactions in immunological testing due to C1 and C1q components of the complement and method for screening for rheumatic factor | |
| EP0280561B1 (en) | Agglutination reagent and method of preparing same | |
| EP0260079A1 (en) | Method of assay | |
| AU732232B2 (en) | Method of coupling ligands to a solid phase in acidic solution and anionic surfactant | |
| CN120522107A (zh) | 一种提高胶乳免疫比浊法试剂的灵敏度的方法 | |
| EP0586693A1 (en) | Technique for prevention of false reactions in immunological testing | |
| JPH03267759A (ja) | 固定化赤血球を用いた免疫学的測定方法 | |
| HK1001234A (en) | Test method and reagent kit therefor | |
| HK1001234B (en) | Test method and reagent kit therefor | |
| JPH02231566A (ja) | 酵素標識レセプター組成物、診断キット、およびリガンド測定法への利用 | |
| JPH1130616A (ja) | 高感度免疫学的測定方法および測定キット |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| 732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19941117 |